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Introduction
Acute lymphoblastic leukemia (ALL) is a malignancy of 
immature lymphoid cells. The over production of malig-
nant cells in the bone marrow inhibits the production of 
other blood cells. ALL is the most prevalent malignancy 
in children, representing 25%-30% of all childhood malig-
nancies (1). Many plants contain components against can-
cer cells that can induce their effects in different stages of 
growth of cancer cells (2). A promising strategy for cancer 
prevention is introducing drugs that block the develop-
ment of cancer (3). Food plays an important role in pre-
venting the onset and progression of cancer. Nowadays, 
medicinal plants have attracted the attention of many 
cancer patients around the world. The scientists have fo-
cused on the biological and therapeutic properties of these 
products (4). Induction of apoptosis in cells is one of the 
targets of anti-cancer therapy (5). Gallic acid (GA) is a 
polyhydroxyphenolic compound that is widely distributed 
in the natural plants, fruits and food and has a wide range 
of biological functions (6).  Many foods such as gallnuts, 
sumac, grape, green tea, oak bark, strawberry, lemon, ba-
nana, pineapple, witch hazel, and apple peel are known to 
be rich in GA (7). GA and its analogs have been reported 
to have many biological activities, including antioxidant 
property (8), anti-tumor (7), anti-mutagenic, and anti-
carcinogenic properties (9). However, the major interest 
in GA and its analogs is related to its antitumor activity. It 
has been shown that propyl, lauryl, methyl gallate induce 
apoptosis and inhibit proliferation in tumor cell lines (10). 
GA has shown no cytotoxicity against normal fibroblast 
and endothelial cells (11). Some studies have shown that 
GA causes DNA fragmentation (10) and is also respon-
sible for suppression of tumor angiogenesis, leading to in-
hibition of tumor metastasis (12). In fact, anti-cancer ac-
tivity of GA has been reported in various cancer cells, such 
as prostate (13), lung, gastric, colon, breast, cervical and 
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Implication for health policy/practice/research/medical education:
Gallic Acid (GA) has anti-cancer property and this effect seems to be through apoptosis induction in lymphoblastic leukemia. 
These results can be a step toward targeted combination or alternative chemotherapy in cancer.
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Introduction: Acute lymphoblastic leukemia (ALL) is the most prevalent leukemia in children. 
Fruits and plants have a wide range of biological functions including anti-proliferative effect. Gallic 
acid (GA), is a polyhydroxyphenolic compound that is widely distributed in the natural plants. The 
aim of the present study was the evaluation of the effect of GA on proliferation inhibition of Jurkat 
cells, the lymphoblastic leukemia cell line. 
Methods: Jurkat cell line was cultured in blood cells culture media in a standard conditions with 
different concentrations of GA (0-100 µm) for 24, 48 and 72 hours. The effect of GA on cell viability 
was measured using MTS assay.
Results: Decline of cell viability to less than 50% was observed at 60, 50 and 30 µm concentrations 
after 24, 48 and 72 hours incubation time, respectively. 
Conclusion: The results demonstrated that the polyphenolic compound, GA with antioxidant 
capability is effective in proliferation inhibition in Jurkat lymphoblastic leukemia cell line with 
a time and dose dependent manner. Therefore, GA may be a potential compound for cancer 
prevention and treatment.
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esophageal cancers (14). As there was no report of the ef-
fect of GA on lymphoblastic leukemia cell line, we aimed 




Lymphoblastic leukemia cell line (Jurkat cell) was cultured 
in RPMI 1640 supplemented with 10% heat-inactivated 
fetal bovine serum (FBS), 100IU/mL penicillin, 0.1 mg/
mL streptomycin (PS) and 0.3 mg/ml L-glutamine. The 
cells were incubated at 37°C in a humidified incubator 
with 5% carbon dioxide. The cells were maintained at the 
concentration of 2×105/ml and then transferred to 96 and/
or 6-well plates for experiments. To determine the viable 
cells, the culture was harvested and the cells were counted 
by the trypan blue staining and standard hemocytometer.
Cell culture and treatment
Jurkat cells were cultured in RPMI-1640 medium contain-
ing 10% FBS. The stock solution of GA was dissolved in 
RPMI-1640, and different concentrations (uM) were pre-
pared in the RPMI-1640 medium.
Assessment of cell viability by MTS assay
This chromogenic assay involves the biological reduction 
by viable cells of the tetrazolium compound 3-(4, 5-di-
methylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2Htetrazolium (or MTS). 
MTS assay reagent is composed of MTS and the elec-
tron coupling agent phenazine methosulfate (PMS). The 
formazan product of MTS reduction is soluble in tissue 
culture medium. This reaction only takes place when mi-
tochondrial reductase enzymes are active, and therefore 
the conversion can be directly related to the viability of 
cells in culture. The MTS reagent alone results in very low 
background absorbance values in the absence of cells. 
Jurkat cells were seeded in above complete media at the 
concentration of 10 × 103 cells per well in 96-well plates 
and allowed to grow overnight. The cells were treated with 
different concentrations (0-100 µM) of GA. After incuba-
tion for 48 hours, 20 µL of MTS (5 mg/mL in phosphate 
buffered saline) was added to each well and incubated for 
3 hours, in the dark. The absorbance was measured at 490-
620 nm by an Elisa reader (stat fax-2100 awarenes).
Statistical analysis
Data were analyzed by SPSS using Kruskal-Wallis test and 
are presented as the means ± standard deviation from at 
least three independent experiments. 
Results
Decrease cell viability by gallic acid
Jurkat cells were incubated with various concentrations 
(0, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100µM) of GA for 24, 
48 and 72 hours. Decrease of cell viability was observed 
after incubation time in treated cells in a time–dependent 
manner (Figure 1). The MTS assay was done to investi-
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Figure 1. A: Decrease of cell viability in the presence of GA 
after 24, 48 and 72 hours (time-dependent). B: Decrease of cell 
viability in Jurkat cells incubated with various concentrations (0, 
20, 40, 80) (dose-dependent) (Magnification 40x).
Figure 2. Jurkat cell viability by MTS assay. Cell viability was 
determined by measuring the mitochondrial metabolism of MTS 
after 24, 48 and 72 hours. 
gate the cell viability. The data obtained from the absorp-
tion at 490 nm was converted to a percentage. The results 
showed a dose- and time-dependent behavior (Figure 2). 
Cell viability was about 93%, 87%, 65%, at a concentration 
of 20μM after 24, 48 and 72 hours, respectively, however 
viability declined to 13%, 8% and 5% at a concentration 
of 100μM after above incubation periods. IC50 (inhibition 
concentration) was about 60μM in 24 hours, about 50μM 
in 48 hours and about 30μM in 72 hours (Figures 2 and 3).
Discussion
Growth inhibition and antiproliferative effect of GA have 
been shown in some tumor cell lines (15). The results of 
our study show that GA in a dose and time dependent 
manner decreased cell proliferation in Jurkat cell line. The 
result showed IC50 about 60μM in 24 hours, about 50μM in 
48 hours and about 30μM in 72 hours. The concentrations 
of drug had significant difference in cell viability in the 
MTS assay. GA inhibitory effect on cell proliferation has 
been studied in several cancer cell lines in various studies, 
which are in agreement with our findings. You and Park 
(16) have shown the effect of GA in 2 types of lung cancer 
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cells (A549 and Calu-6). The inhibition of the growth of 
lung cancer cells and induction of cell death were related 
to GSH (glutathione) depletion as well as reactive oxygen 
species (ROS) level changes. The induction of apoptosis 
has been shown to be related to ROS in Larry et al study 
in prostate cancer cells. In this study, 80 μg/ml GA has the 
maximum inhibitory effect in 24 hours and caused activa-
tion of apoptosis pathway (17). Chia et al (18) studied the 
anticancer effects of GA in oral cancer cell lines including 
UM1, UM2, SCC-4 and SEC-9. They showed that the re-
quired concentration of GA for the induction of apoptosis 
was different in various cell lines. Lu et al (12) have stud-
ied GA-induced cell death and the anti-proliferation, anti-
invasion, and angiogenesis in human glioma cells. They 
showed that the inhibition of cell viability by GA was dose 
dependent. Madlener et al (19) studied the effect of GA in 
promyelocytic leukemia cells (HL-60) They showed that 
apoptosis induced by GA is dose dependent. Other studies 
have demonstrated the effect of GA on gastric cancer cells 
(20). You et al (7) studied the effect of GA in Hela cervical 
cancer cells. They showed that GA was able to inhibit the 
growth of Hela cells and to induce apoptosis. GA-induced 
Hela cell death was also accompanied by ROS increase 
and GSH depletion. The effect of GA on Leukemia cells 
(K562) and L1210 (15,21) was also in consistent with our 
data. Our study showed that GA could inhibit cell pro-
liferation in lymphoblastic leukemia cell line which was 
consistent with the studies of other cell lines. 
Conclusion
It seems from the study that decrease of Jurkat cell num-
bers in the presence of GA is dependent to the dose- and 
time which is a favorable effect of anti-cancer treatments. 
GA may help in cancer combination- chemotherapy but it 
needs to be investigated in other lymphoblastic cell lines, 
ALL lymphoblasts and then in vivo experimental models.
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